Cargando…
Methodological Issues in Randomized Clinical Trials for Prodromal Alzheimer's and Parkinson's Disease
Alzheimer's disease (AD) and Parkinson's disease (PD) are the first and second most common neurodegenerative disorders, respectively. Both are proteinopathies with inexorable courses and no approved disease-modifying therapies. A substantial effort has been made to identify interventions t...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377160/ https://www.ncbi.nlm.nih.gov/pubmed/34421799 http://dx.doi.org/10.3389/fneur.2021.694329 |